Common drugs may shield lungs from cancer treatment damage
NCT ID NCT06634056
Summary
This study aims to see if adding two existing drugs, pentoxifylline and vitamin E, to standard lung cancer treatment can reduce lung damage caused by radiation therapy. Researchers will enroll 150 adults with stage III lung cancer who are receiving chemotherapy, radiation, and immunotherapy. The goal is to lower the risk of serious lung inflammation and improve patients' quality of life during and after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Health Network - Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2C1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.